Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07091526 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.
Trial Details
NCT Number NCT07091526
Lead Sponsor Hepatopancreatobiliary Surgery Institute of Gansu Province
Conditions
(from sponsor)		 Serum Uric Acid
Related terms Pancreatic Neoplasms
Enrollment 168 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov